Alteration of gut microbiota in patients with advanced hepatocellular carcinoma.

被引：0
|
作者：
Charoenthanadhol, Thanakorn
Wirasorn, Kosin
Sookprasert, Aumkhae
Chindaprasert, Jarin
Sanlung, Thanachai
Watcharenwong, Piyakarn
Putraveephong, Siraphong
Phetcharaburanin, Jutarop
机构：
[1] Khon Kaen Univ, Fac Med, Muang, Thailand
[2] Khon Kaen Univ, Fac Med, Mueang Khon Kaen, Thailand
[3] Khon Kaen Univ, Fac Med, Khon Kaen, Thailand
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.641
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：641 / 641
页数：1
相关论文
共 50 条
  • [41] Alteration of indicator gut microbiota in patients with chronic sinusitis
    Michalik, Michal
    Podbielska-Kubera, Adrianna
    Basinska, Anna Maria
    Szewc, Monika
    Galecka, Miroslawa
    Schwiertz, Andreas
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (09)
  • [42] Alteration of the oral and gut microbiota in patients with Kawasaki disease
    Zeng, Qinghuang
    Zeng, Renhe
    Ye, Jianbin
    PEERJ, 2023, 11
  • [43] Organ-specific responses to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma.
    Cheon, Jaekyung
    Jung, Sanghoon
    Kang, Beodeul
    Kim, Hyeyeong
    Kim, Chan
    Chon, Hongjae
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Plasma growth hormone as a prognostic biomarker to durvalumab and tremelimumab in patients with advanced hepatocellular carcinoma.
    Chamseddine, Shadi
    LaPelusa, Michael Brian
    Xiao, Lianchun
    Abugabal, Yehia I.
    Lee, Sunyoung S.
    Hu, Zishuo Ian
    Hu, Zishuo Ian
    Hatia, Rikita
    Hassan, Manal
    Yao, James C.
    Duda, Dan G.
    Datar, Saumil
    Amin, Hesham M.
    Kaseb, Ahmed Omar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Community characteristics and relationship between gut microbiota and intratumoral microbiota in hepatocellular carcinoma
    Lin, Huangpeng
    Ma, Zexian
    Li, Jin
    Zhu, Heping
    Huang, Xuefeng
    Chen, Huimin
    Tu, Liang
    Lian, Yifan
    Su, Yongjie
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [46] Molecular characteristics of patients with resectable hepatocellular carcinoma.
    Zeng, Daobing
    Wang, Menglong
    Wu, Jushan
    Lin, Dongdong
    Guo, Qingliang
    Li, Chuanyun
    Zhang, Haitao
    Di, Liang
    Zhao, Xiaofei
    Ma, Chao
    Gao, Daming
    Liu, Zhaobo
    Fu, Zhi
    Sun, Libo
    Zhang, Qikun
    Li, Guangming
    Guo, Rongyun
    Wang, Huina
    Zhang, Yanrui
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] A combination of capecitabine and thalidomide in patients with hepatocellular carcinoma.
    Jeong, W.
    Chun, H. G.
    Cer, D.
    Sekhri, V.
    Kim-Schluger, L.
    Wolf, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 213S - 213S
  • [48] Etiologies of cirrhosis by ethnicities of patients with hepatocellular carcinoma.
    Chang, Jeremy
    Ajmera, Veeral
    Fowler, Kathryn J.
    Burgoyne, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 515 - 515
  • [49] Analysis of liver transplanted patients for hepatocellular carcinoma.
    Emiroglu, R
    Sozen, H
    Karakayali, F
    Karakayali, H
    Torgay, A
    Yilmaz, U
    Haberal, M
    LIVER TRANSPLANTATION, 2006, 12 (05) : C47 - C47
  • [50] Hepatitis G virus in patients with hepatocellular carcinoma.
    Haydon, GH
    Jarvis, LM
    Simmonds, P
    Hayes, PC
    HEPATOLOGY, 1998, 28 (04) : 219A - 219A
12345